Skip to main content
. 2016 Nov 5;34:105–109. doi: 10.1007/8904_2016_13

Table 2.

Compares the features of the case described here with the four siblings (patients 1–4) previously described by Galmiche et al. in 2011

Case 1 Case 2 Case 3 Case 4 Current case
HCM age at diagnosis 11 months 12 months 9 months 9 months 8 months
Hepatomegaly + + +
Elevated liver enzymes + + + +
Lactic acidosis + + + + +
FTT + + + ++ +
SNHL + (cochlear implant)
MRI/MRSbrain Not reported Not reported Cortical hypergyria Cortical hypergyria Lactate peak
MRPL3 genotype c.950>G (Pro317Arg)
255 kbp contiguous gene deletion
c.950>G (Pro317Arg)
255 kbp contiguous gene deletion
c.950>G (Pro317Arg)
255 kbp contiguous gene deletion
c.950>G (Pro317Arg)
255 kbp contiguous gene deletion
c.950>G (Pro317Arg)
c.49delC p.(Arg17Aspfs*57)
MRC studies Decreased complex I, IV, V Decreased complex I, IV, V Decreased complex I, IV Decreased complex I, IV, V Not performed
Outcome Cardiac death at 17 months Cardiac death at 15 months Alive at 3 years, stable cardiomyopathy, failure to thrive, psychomotor retardation Alive at 3 years, stable cardiomyopathy, severe failure to thrive, psychomotor retardation Cardiac death at 11 months. Cirrhosis and interstitial nephritis
Additional findings at autopsy Hepatic cirrhosis
Interstitial nephritis

HCM hypertrophic cardiomyopathy, FTT failure to thrive, SNHL sensorineural hearing loss, MRI magnetic resonance imaging, MRS magnetic resonance spectroscopy, MRC mitochondrial respiratory chain, + present